Table 2.
Comparison of mean scores of different study variables at baseline between three groups
| Variables | Group | n | Mean | SD | SE | Minimum | Maximum | P |
|---|---|---|---|---|---|---|---|---|
| GI | Group 1 | 15 | 1.00 | 0.34 | 0.09 | 0.6 | 1.9 | 0.46 |
| Group 2 | 15 | 0.93 | 0.23 | 0.06 | 0.5 | 1.3 | ||
| Group 3 | 15 | 0.88 | 0.20 | 0.05 | 0.5 | 1.2 | ||
| PI | Group 1 | 15 | 1.07 | 0.18 | 0.05 | 0.8 | 1.3 | 0.34 |
| Group 2 | 15 | 1.09 | 0.26 | 0.07 | 0.3 | 1.4 | ||
| Group 3 | 15 | 0.97 | 0.23 | 0.06 | 0.5 | 1.3 | ||
| PPD | Group 1 | 15 | 4.78 | 0.98 | 0.25 | 3.15 | 6.63 | 0.26 |
| Group 2 | 15 | 4.55 | 0.87 | 0.22 | 3.13 | 5.89 | ||
| Group 3 | 15 | 4.24 | 0.78 | 0.20 | 3.02 | 5.67 | ||
| CAL | Group 1 | 15 | 4.54 | 1.16 | 0.30 | 2.16 | 5.96 | 0.91 |
| Group 2 | 15 | 4.55 | 0.79 | 0.20 | 3.34 | 5.98 | ||
| Group 3 | 15 | 4.41 | 0.98 | 0.25 | 2.88 | 6.39 | ||
| Aa | Group 1 | 15 | 980.3 | 155.0 | 40.0 | 782 | 1325 | 0.20 |
| Group 2 | 15 | 1064.0 | 160.4 | 41.4 | 827 | 1378 | ||
| Group 3 | 15 | 964.4 | 161.8 | 41.8 | 697 | 1239 | ||
| Tf | Group 1 | 15 | 1511.7 | 260.6 | 67.3 | 1015 | 1998 | 0.10 |
| Group 2 | 15 | 1346.3 | 518.3 | 133.8 | 736 | 2589 | ||
| Group 3 | 15 | 1193.3 | 365.1 | 94.3 | 449 | 1874 | ||
| Pg | Group 1 | 15 | 521.9 | 139.9 | 36.1 | 236 | 712 | 0.30 |
| Group 2 | 15 | 570.9 | 185.2 | 47.8 | 301 | 903 | ||
| Group 3 | 15 | 473.1 | 180.6 | 46.6 | 120 | 789 |
*Statistically significant (P<0.05). Group 1 – SRP; Group 2 – SRP + 1% chlorhexidine gel; Group 3 – SRP + 2% nanocurcumin gel; CFU/ml – Colony-forming units/ml; SRP – Scaling and root planing; GI – Gingival index; PI – Plaque index; PPD – Probing pocket depth; CAL – Clinical attachment level; Aa – Aggregatibacter actinomycetemcomitans (CFU/ml); Tf – Tannerella forsythia (CFU/ml); Pg – Porphyromonas gingivalis (CFU/ml); SD – Standard deviation; SE – Standard error; P – P value; n – No of subjects